Skip to main content
The American Journal of Tropical Medicine and Hygiene logoLink to The American Journal of Tropical Medicine and Hygiene
. 2020 Jan;102(1):7–8. doi: 10.4269/ajtmh.19-0539

Intraocular Infiltration

Koju Kamoi 1,*, Kyoko Ohno-Matsui 1
PMCID: PMC6947777  PMID: 31971149

A 58-year-old man presented with general malaise and showed positive results for human T-cell leukemia virus type 1 (HTLV-1) infection. As blood tests revealed abnormal leukocytes and flower cells, smoldering-type adult T-cell leukemia/lymphoma (ATL) was diagnosed. After 7 years, the condition changed to acute-type ATL. Blood tests identified an increase in CD4 from 995 cells/µL to 1,256 cells/µL and monoclonal integration of HTLV-1 provirus into tumor cells. Treatment was started with chemotherapy and allogeneic bone marrow transplantation. During follow-up, he was referred to the ophthalmology department after experiencing sudden visual loss in the right eye.

Slit-lamp examination revealed cellular infiltration in the anterior chamber and vitreous humor. Fundus examination showed yellowish-white infiltrative foci associated with protrusions in the retina. Optical coherence tomography revealed massive solid infiltrative foci below the retinal pigment epithelium (Figure 1). As differential diagnoses for co-infections of the eye, our recent nationwide survey revealed cytomegalovirus (CMV) as a major cause of opportunistic infection in the eye of ATL patients, followed by herpesvirus and toxoplasma.1 In addition, co-infections of the eye in immunocompetent patients are not frequently confirmed using serologic diagnostic methods.2 Multiplex polymerase chain reaction (PCR) and broad-range PCR of a sample of aqueous humor, therefore, ruled out viral (human simplex virus-1 and 2, varicella zoster virus, Epstein–Barr virus, CMV, and human herpesvirus 6–8), toxoplasma, tuberculosis, syphilis, and bacterial and fungal infections, ruling out opportunistic infection and allowing the diagnosis of intraocular leukemic cell infiltration.3 Elevated lesions on the retina improved after two vitreous injections of 400 μg/0.1 mL of methotrexate and subsided with five sessions of 2-Gy radiotherapy. Corresponding to this combination therapy, retinal lesions gradually resolved within 6 months (Figure 2).

Figure 1.

Figure 1.

Yellowish-white infiltrative foci associated with protrusions in the retina (upper figure). Optical coherence tomography reveals massive solid infiltrative foci below the retinal pigment epithelium (lower figure). White line represents scan line. This figure appears in color at www.ajtmh.org.

Figure 2.

Figure 2.

Infiltration is reduced 6 months after vitreous injection of methotrexate concomitant with radiotherapy. This figure appears in color at www.ajtmh.org.

Globally, HTLV-1 infection is now the focus of attention, since the discovery that more than 40% of adults from Aboriginal communities in central Australia are infected with HTLV-1.4 This infection causes ATL and also visual impairment by ATL-related ocular manifestations.5 As HTLV-1–associated ATL is a neoplasia characterized by massive invasion of leukemic cells into various organs, physicians should keep in mind that intraocular infiltration is the most frequent manifestation observed among HTLV-1–associated ATL patients.1

REFERENCES

  • 1.Kamoi K, Okayama A, Izumo S, Hamaguchi I, Uchimaru K, Tojo A, Ohno-Matsui K, 2018. Adult T-cell leukemia/lymphoma-related ocular manifestations: analysis of the first large-scale nationwide survey. Front Microbiol 9: 3240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.de-la-Torre A, et al. 2019. Coinfections and differential diagnosis in immunocompetent patients with uveitis of infectious origin. BMC Infect Dis 19: 91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Mochizuki M, Sugita S, Kamoi K, Takase H, 2017. A new era of uveitis: impact of polymerase chain reaction in intraocular inflammatory diseases. Jpn J Ophthalmol 61: 1–20. [DOI] [PubMed] [Google Scholar]
  • 4.Martin F, Tagaya Y, Gallo R, 2018. Time to eradicate HTLV-1: an open letter to WHO. Lancet 391: 1893–1894. [DOI] [PubMed] [Google Scholar]
  • 5.Kamoi K, Mochizuki M, 2012. HTLV infection and the eye. Curr Opin Ophthalmol 23: 557–561. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Tropical Medicine and Hygiene are provided here courtesy of The American Society of Tropical Medicine and Hygiene

RESOURCES